Methotrexate pharmacogenetics: the first step toward individualized therapy in rheumatoid arthritis.
about
Role of key TYMS polymorphisms on methotrexate therapeutic outcome in portuguese rheumatoid arthritis patientsPharmacogenetics of treatment response in psoriatic arthritisFolic acid pathway single nucleotide polymorphisms associated with methotrexate significant adverse events in United States veterans with rheumatoid arthritisPrediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms.Monotherapy with methotrexate for primary central nervous lymphoma has single agent activity in the absence of radiotherapy: a single institution cohort.Generation of novel pharmacogenomic candidates in response to methotrexate in juvenile idiopathic arthritis: correlation between gene expression and genotype.Systemic methotrexate therapy for psoriasis: past, present and future.Profiling single nucleotide polymorphisms (SNPs) across intracellular folate metabolic pathway in healthy IndiansTLR signaling modulates side effects of anticancer therapy in the small intestine.Studies of the efficacy and safety of methotrexate at dosages over 8 mg/week using the IORRA cohort database.Can clinical factors at presentation be used to predict outcome of treatment with methotrexate in patients with early inflammatory polyarthritis?Adverse drug reactions caused by methotrexate in Saudi populationPsoriatic arthritis: genetic susceptibility and pharmacogenetics.Involvement of Multiple Transporters-mediated Transports in Mizoribine and Methotrexate Pharmacokinetics.Folylpolyglutamate synthase is a major determinant of intracellular methotrexate polyglutamates in patients with rheumatoid arthritis.Pharmacogenetics: implications for therapy in rheumatic diseases.Genetic risk factors for drug-induced liver injury in rheumatoid arthritis patients using low-dose methotrexate.Methotrexate pharmacogenetics in rheumatoid arthritis: a status report.Current approaches for TYMS polymorphisms and their importance in molecular epidemiology and pharmacogenetics.Folate supplementation reduces the side effects of methotrexate therapy for psoriasis.Pharmacogenetics: can genes determine treatment efficacy and safety in JIA?Role of single nucleotide polymorphisms in pharmacogenomics and their association with human diseases.Pharmacogenetics and pharmacogenomics in psoriasis treatment: current challenges and future prospects.The Role of Pharmacogenetics in Chronic Plaque Psoriasis: Update of the Literature.Intra-articular methotrexate associated to lipid nanoemulsions: anti-inflammatory effect upon antigen-induced arthritis.Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) Study.Safety concerns on the development of novel therapeutic drugs.(1)H NMR-based metabolomic analysis for identifying serum biomarkers to evaluate methotrexate treatment in patients with early rheumatoid arthritis.Determination of methotrexate in biological fluids and a parenteral injection using terbium-sensitized method.Current concepts in the genetic diagnostics of rheumatoid arthritis.SLC19A1 80G allele as a biomarker of methotrexate-related gastrointestinal toxicity in Portuguese rheumatoid arthritis patients.A genetic marker at the OLIG3/TNFAIP3 locus associates with methotrexate continuation in early inflammatory polyarthritis: results from the Norfolk Arthritis Register.Plasma total homocysteine level and methylenetetrahydrofolate reductase 677C>T genetic polymorphism in Japanese patients with rheumatoid arthritis.Chromosome conformation signatures define predictive markers of inadequate response to methotrexate in early rheumatoid arthritis.Nonassociation of homocysteine gene polymorphisms with treatment outcome in South Indian Tamil Rheumatoid Arthritis patients.Correlation of genetic polymorphisms with clinical outcomes in pemetrexed-treated advanced lung adenocarcinoma patients.Reduced folate carrier-1 80G > A gene polymorphism is not associated with methotrexate treatment response in South Indian Tamils with rheumatoid arthritis.
P2860
Q21131938-E1DC0086-F441-402E-838A-09754218B718Q28081252-BFF81AB9-3D47-46CC-A2E4-3CF7570160F9Q28394552-51CB6EE4-7762-4B80-87D6-AEDF4BF1EBD3Q33747444-BE527D36-560D-476D-B55A-B61DA5015E0DQ33906988-35C03A5D-B116-47AA-86A3-3AE568BB79E7Q34235121-BA545358-33DE-4936-B087-327DD880A203Q34356265-71560F42-E45D-4941-B99A-0925445C7450Q35010441-F2A05FC6-6336-4D8C-8764-CD161EE32104Q35114570-A3575E86-D1EE-4F15-96AC-51AFF0CE1448Q35610255-10FF2062-3F2D-4B2B-A54E-D260499285DFQ37000103-AF49279A-6227-4E47-BD80-3B9E5ACABE67Q37099103-9B99BB15-DABA-4A8A-A210-3F25B3FD16E7Q37120837-C3CC2310-110D-4A95-AF69-AE7FFC6A0730Q37148784-302C0D36-C018-45F5-880F-F290FF69E304Q37345390-C19A3867-559E-41B9-A3A0-193E3B6249FAQ37913989-8F835222-5135-450A-B73A-2D23189843BFQ38068540-C8E1201E-EFC5-482F-B7A9-E962C1631536Q38080147-72FD2FB7-BFF7-44F6-9817-565B5B99CEC5Q38127717-1C1D168D-999B-435F-A058-CFCB76A6F8CDQ38223934-8B184D81-1276-4543-BBDF-3472FC591C30Q38238947-2CB1383F-86DF-44F4-9D7A-3F096B9DBBE9Q38495339-6D91C9C9-5993-447F-8D27-E8A9A3E83BDDQ38856372-05458374-1DCB-4385-AD87-96BDE5D5AAE7Q39218034-EA947318-6419-4E3B-90AE-5B1F1E827111Q39461770-ACEA3FCC-E6F9-4A97-BE7E-CDBF6B6C1E3EQ40298171-59227464-245E-42FB-8AD5-62BE2EA19A8DQ42138494-82E45C58-3CE2-4A26-9EC7-26DCD8A9B21FQ42572005-951327B6-6A36-4DEF-BBF9-7D9DBC37AECFQ42927790-53BD88C9-A0E9-48A0-BFF3-E2B10038A076Q42970803-379CDAA3-E6DE-41B1-8D95-B4978E489234Q45055039-015424D3-08A8-4A18-A8C8-E564F27D6593Q45252920-8F64C308-FF03-4137-8B73-39BD68978080Q46090014-D78FF337-8454-4149-941B-1D478E7D6A3FQ48148502-60F4200B-1538-4D18-A706-63F786DFA3F3Q48214252-8F794D06-608D-4CB2-8775-878BE18C0828Q53564503-6D6AA939-1E1F-4D6B-BD03-CA7D121D20F8Q55058941-77B2FB0C-2FF1-435E-AA31-F5DE0B24568E
P2860
Methotrexate pharmacogenetics: the first step toward individualized therapy in rheumatoid arthritis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Methotrexate pharmacogenetics: ...... erapy in rheumatoid arthritis.
@ast
Methotrexate pharmacogenetics: ...... erapy in rheumatoid arthritis.
@en
type
label
Methotrexate pharmacogenetics: ...... erapy in rheumatoid arthritis.
@ast
Methotrexate pharmacogenetics: ...... erapy in rheumatoid arthritis.
@en
prefLabel
Methotrexate pharmacogenetics: ...... erapy in rheumatoid arthritis.
@ast
Methotrexate pharmacogenetics: ...... erapy in rheumatoid arthritis.
@en
P2860
P356
P1476
Methotrexate pharmacogenetics: ...... erapy in rheumatoid arthritis.
@en
P2093
Howard L McLeod
Prabha Ranganathan
P2860
P304
P356
10.1002/ART.21762
P577
2006-05-01T00:00:00Z